Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Liyao Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Affiliated Hospital 3, Soochow University, Changzhou, 213003, P. R. China. Hauptthemen laut MEDLINE: Reperfusion Injury, Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Nanoparticles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Renal ischemia‐reperfusion injury (IRI) is a common disease with high morbidity and mortality. Renal IRI can cause the disorder of immune microenvironment and reprograming the immune microenvironment to alleviate excessive inflammatory response is crucial for its treatment. Cytokine IL‐33 can improve the immune inflammatory microenvironment by modulating both innate and adaptive immune cells, and serve as an important target for modulating immune microenvironment of renal IRI. Herein, we report that bilobetin‐functionalized ultrasmall Cu 2− x Se nanoparticles (i.e., CSPB NPs) can activate the PKA/p‐CREB/IL‐33/ST2 signaling pathway to regulate innate and adaptive immune cells for reprograming the immune microenvironment of IRI‐induced acute kidney injury. The biocompatible CSPB NPs can promote the polarization of M1‐like macrophages into M2‐like macrophages, and the expansion of ILC2 and Treg cells by activating IL‐33/ST2 to modulate the excessive immune inflammatory response of renal IRI. More importantly, they can rapidly accumulate at the injured kidney to significantly alleviate IRI. This work demonstrates that modulating the expression of cytokines to reprogram immune microenvironment has great potential in the treatment of renal IRI and other ischemic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Affiliated Hospital 3, Soochow University, Changzhou, 213003, P. R. China.
- Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Suzhou Medical College, Soochow University, C…
ORCID-Profile: Zhen Li
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
- State Key Laboratory of Radiation Medicine and Protection
Zitieren
APA
Xu, L., Xing, Z., Yuan, J., Han, Y., Jiang, Z., Han, M., Hou, X., Xing, W., & Li, Z. (2024). Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303276
Vancouver
Xu L, Xing Z, Yuan J, Han Y, Jiang Z, Han M, et al. Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303276
BibTeX
@article{Xu2024,
author = {Xu, Liyao and Xing, Zhaoyu and Yuan, Jiaxin and Han, Yaobao and Jiang, Zhilin and Han, Mengxiao and Hou, Xianao and Xing, Wei and Li, Zhen},
title = {Ultrasmall Nanoparticles Regulate Immune Microenvironment by Activating IL‐33/ST2 to Alleviate Renal Ischemia‐Reperfusion Injury},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303276}
}
EUVIMED